Within an , I outlined a task to build up a Modeling & Simulation (M&S) timing model – being an alternate method of dedicated studies – to look for the ideal time to vaccinate women that are pregnant. This model could then be further used to predict infant antibody (Ab) levels at birth and eventually be utilized for an invaluable quantitative method of vaccine development.
Continue reading “The need for Modeling and Simulation in Vaccine Development – Certara”